Stroke in hemoglobin (SD) sickle cell disease with moyamoya: Successful hydroxyurea treatment after cerebrovascular bypass surgery

Blood

Volumn 97, Issue 7, 2001, Pages 2165-2167

  Schmugge, Markus ^b   Frischknecht, Hannes ^b   Yonekawa, Yasuhiro ^b   Baumgartner, Ralf W ^b   Boltshauser, Eugen ^b   Humbert, James ^a  

^a Geneva Children's University Hospital   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; HYDROXYUREA;

APHASIA; ARTICLE; BLOOD TRANSFUSION; BRAIN ARTERY BYPASS; CASE REPORT; CEREBROVASCULAR ACCIDENT; ETHNOLOGY; FLOW RATE; FOLLOW UP; HEMIPARESIS; HUMAN; MALE; MOYAMOYA DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RELIGION; SCHOOL CHILD; SICKLE CELL ANEMIA; STROKE;

EID: 0035313395     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.7.2165     Document Type: Article

References (23)

1. Hemoglobin SD disease
2. Moyamoya disease status, 1998
3. Moyamoya in children with sickle cell anemia and cerebrovascular occlusion
4. Cerebrovascular complications of sickle-cell anemia
5. Encephaloduroarteriosynangiosis in a child with sickle cell anaemia and moyamoya disease
6. Midwest experience with moyamoya disease
7. Risk factors of moyamoya disease in Canada and the USA
8. EC-IC bypass improves chronic ischemia in a patient with moyamoya disease secondary to sickle cell disease: An in vivo microdialysis study
9. Management of cerebral vasculopathy in children with sickle cell anaemia
10. Stroke in sickle cell disease: Demographic, clinical, and therapeutic considerations
11. Cerebrovascular accidents in sickle cell disease: Rates and risk factors
12. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography
13. Management of sickle cell disease
14. Effect of transfusion therapy on arteriographic abnormalities and on the recurrence of stroke in sickle cell disease
15. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease
16. Direct and combined revascularisation in pediatric moyamoya disease
17. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia: Investigators of the multicenter study of hydroxyurea in sickle cell anemia
18. Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease: The French study group on sickle cell disease
19. Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial
20. Hydroxyurea is safe and effective in 2 to 5 year old children with sickle cell disease
21. A two-year pilot trial of hydroxyurea in very young children with sickle cell disease
22. Hydroxyurea: An alternative to transfusion therapy for stroke in sickle cell anemia
23. Progressive pulmonary hypertension and pulmonary insufficiency in sickle cell patients who respond to hydroxyurea